NFKB1 and non-small cell lung carcinoma: Chemotherapeutic agents induced NF-κB activity in NSCLC cell lines, increasing the cells resistance to these agents [17] suggesting that in addition to a role in tumor cell evasion of apoptosis, NF-κB may render lung tumor cells more resistant to chemotherapeutic agents.